{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:23:52Z","timestamp":1769527432266,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ad.2012.03.014","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T20:46:02Z","timestamp":1347309962000},"page":"261-263","source":"Crossref","is-referenced-by-count":4,"title":["Enfermedad de Fabry: espectro cl\u00ednico de los angioqueratomas"],"prefix":"10.1016","volume":"104","author":[{"given":"R.M.","family":"Guinovart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bielsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pintos-Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ferr\u00e1ndiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2012.03.014_bib0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0001-7310(04)76853-2","article-title":"Diagn\u00f3stico y tratamiento enzim\u00e1tico sustitutivo de la enfermedad de Fabry","volume":"95","author":"Mart\u00ednez-Mench\u00f3n","year":"2004","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.014_bib0010","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermott","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.ad.2012.03.014_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry outcome survey","volume":"157","author":"Orteu","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.03.014_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0001-7310(05)73102-1","article-title":"Lesiones cut\u00e1neas rojo-viol\u00e1ceas y lineales en extremidad superior","volume":"9","author":"Ferrando","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2012.03.014_bib0025","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.0303-6987.2005.00366.x","article-title":"Fucosidosis with angiokeratoma. Immunohistochemical and electronmicroscopic study of a new case and literature review","volume":"32","author":"Kanitakis","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2012.03.014_bib0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1365-2133.2002.04827.x","article-title":"Angiokeratoma corporis diffusum in a Spanish patient with aspartylglucosaminuria","volume":"147","author":"Vargas-D\u00edez","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.03.014_bib0035","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1742-1241.2011.02695.x","article-title":"Fabry disease in Spain: Description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)","volume":"65","author":"Barba-Romero","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ad.2012.03.014_bib0040","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2009.11.007","article-title":"Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease","volume":"156","author":"Schiffmann","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.ad.2012.03.014_bib0045","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00431-009-0937-9","article-title":"Fabry disease in children and the effects of enzyme replacement treatment","volume":"168","author":"Pintos-Morell","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ad.2012.03.014_bib0050","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.0022-202X.2004.22425.x","article-title":"Monitoring the 3-year efficacy of enzyme replacement therapy in Fabry disease by repeated skin biopsies","volume":"122","author":"Thurberg","year":"2004","journal-title":"J Invest Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.ad.2013.05.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000}}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731012003419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731012003419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T23:03:50Z","timestamp":1542755030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731012003419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0001731012003419"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2012.03.014","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}